Blog Tags: Drug Research and Development
Cracking the Code of Polymorphism in Organic Crystals: A Breakthrough in Pharmaceutical Research
Explore the intricate world of organic crystal polymorphism in drug development as researchers decode surface and bulk nucleation rates, unveiling the key to preventing unwanted crystallization. A breakthrough in understanding molecular packing dynamics sheds light on preventing drug failures such as Abbott Laboratory’s Norvir® recall.
Read More
